Guidi, L.; Pellizzari, G.; Tarantino, P.; Valenza, C.; Curigliano, G.
Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges. Cancers 2023, 15, 1130.
https://doi.org/10.3390/cancers15041130
AMA Style
Guidi L, Pellizzari G, Tarantino P, Valenza C, Curigliano G.
Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges. Cancers. 2023; 15(4):1130.
https://doi.org/10.3390/cancers15041130
Chicago/Turabian Style
Guidi, Lorenzo, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza, and Giuseppe Curigliano.
2023. "Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges" Cancers 15, no. 4: 1130.
https://doi.org/10.3390/cancers15041130
APA Style
Guidi, L., Pellizzari, G., Tarantino, P., Valenza, C., & Curigliano, G.
(2023). Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges. Cancers, 15(4), 1130.
https://doi.org/10.3390/cancers15041130